Delivery Order SPE2DB22D2005-SPE2DB25FJEJ6

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,594.48 firm fixed-price delivery order is for the supply of Cosentyx (Secukinumab) 300mg dose-2 prefilled syringes. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx (secukinumab) 300 mg dose prefilled syringes. The $16,595.61 firm-fixed-price delivery order contract has a performance period through May 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 syringes. The $4,767.17 firm fixed-price contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to AmerisourceBergen Drug Corporation. The $3,258.39 firm fixed-price delivery order is for the supply of Cosentyx pharmaceutical products, specifically the 300mg dose in pre-filled syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose syringes to the Defense Logistics Agency (DLA). The $11,139.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the company's Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award, valued at $15,258.91, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (secukinumab) 300mg doses, a specialty medication used to treat certain autoimmune conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg prefilled syringes. The award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,231.56 delivery order contract is for the supply of Cosentyx (secukinumab) 300mg dose syringes, a medication used to treat various autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 15, 2025. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,472.55 firm fixed price delivery order is for the supply of Cosentyx (secukinumab) 300mg dosage medication. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $8,433.71 firm fixed-price delivery order is for the supply of Cosentyx (secukinumab) 300 mg doses. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025 for providing a...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJEJ6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx (secukinumab) 300mg doses in pre-filled syringes. The $53,065.37 firm fixed-price delivery order has a completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed did not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:43 PM